Non-surgical Lateral Epicondylitis Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: N5D128C236D2EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The non surgical treatment includes extracorporeal shock wave therapy, braces, medications and physical therapies. Various anti inflammatory drugs (NSAIDS) such as ibuprofen, aspirin and cortisone are administered to control pain in lateral epicondylitis.

This report contains market size and forecasts of Non-surgical Lateral Epicondylitis Treatment in Global, including the following market information:

Global Non-surgical Lateral Epicondylitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Non-surgical Lateral Epicondylitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Extracorporeal Shock Wave Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Non-surgical Lateral Epicondylitis Treatment include Bayer AG, GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck Sharp & Dohme Corp. and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-surgical Lateral Epicondylitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Non-surgical Lateral Epicondylitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Non-surgical Lateral Epicondylitis Treatment Market Segment Percentages, by Type, 2021 (%)
  • Extracorporeal Shock Wave Therapy
  • Braces
  • Medications and Physical therapies
  • Others
Global Non-surgical Lateral Epicondylitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Non-surgical Lateral Epicondylitis Treatment Market Segment Percentages, by Application, 2021 (%)
  • Athlete
  • Others
Global Non-surgical Lateral Epicondylitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Non-surgical Lateral Epicondylitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Non-surgical Lateral Epicondylitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Non-surgical Lateral Epicondylitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Bayer AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.
  • Merck Sharp & Dohme Corp.
  • Pfizer Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Non-surgical Lateral Epicondylitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Non-surgical Lateral Epicondylitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NON-SURGICAL LATERAL EPICONDYLITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Non-surgical Lateral Epicondylitis Treatment Market Size: 2021 VS 2028
2.2 Global Non-surgical Lateral Epicondylitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Non-surgical Lateral Epicondylitis Treatment Players in Global Market
3.2 Top Global Non-surgical Lateral Epicondylitis Treatment Companies Ranked by Revenue
3.3 Global Non-surgical Lateral Epicondylitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Non-surgical Lateral Epicondylitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Non-surgical Lateral Epicondylitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-surgical Lateral Epicondylitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Non-surgical Lateral Epicondylitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Non-surgical Lateral Epicondylitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Non-surgical Lateral Epicondylitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Extracorporeal Shock Wave Therapy
  4.1.3 Braces
  4.1.4 Medications and Physical therapies
  4.1.5 Others
4.2 By Type - Global Non-surgical Lateral Epicondylitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Non-surgical Lateral Epicondylitis Treatment Market Size, 2021 & 2028
  5.1.2 Athlete
  5.1.3 Others
5.2 By Application - Global Non-surgical Lateral Epicondylitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Non-surgical Lateral Epicondylitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.3.2 US Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.3.3 Canada Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.4.2 Germany Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.3 France Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.5 Italy Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.6 Russia Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.5.2 China Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.3 Japan Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.5.6 India Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.7.3 Israel Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028
  6.7.5 UAE Non-surgical Lateral Epicondylitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Corporate Summary
  7.1.2 Bayer AG Business Overview
  7.1.3 Bayer AG Non-surgical Lateral Epicondylitis Treatment Major Product Offerings
  7.1.4 Bayer AG Non-surgical Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Bayer AG Key News
7.2 GlaxoSmithKline plc.
  7.2.1 GlaxoSmithKline plc. Corporate Summary
  7.2.2 GlaxoSmithKline plc. Business Overview
  7.2.3 GlaxoSmithKline plc. Non-surgical Lateral Epicondylitis Treatment Major Product Offerings
  7.2.4 GlaxoSmithKline plc. Non-surgical Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline plc. Key News
7.3 Johnson & Johnson Services, Inc.
  7.3.1 Johnson & Johnson Services, Inc. Corporate Summary
  7.3.2 Johnson & Johnson Services, Inc. Business Overview
  7.3.3 Johnson & Johnson Services, Inc. Non-surgical Lateral Epicondylitis Treatment Major Product Offerings
  7.3.4 Johnson & Johnson Services, Inc. Non-surgical Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Services, Inc. Key News
7.4 Merck Sharp & Dohme Corp.
  7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
  7.4.2 Merck Sharp & Dohme Corp. Business Overview
  7.4.3 Merck Sharp & Dohme Corp. Non-surgical Lateral Epicondylitis Treatment Major Product Offerings
  7.4.4 Merck Sharp & Dohme Corp. Non-surgical Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Pfizer Inc.
  7.5.1 Pfizer Inc. Corporate Summary
  7.5.2 Pfizer Inc. Business Overview
  7.5.3 Pfizer Inc. Non-surgical Lateral Epicondylitis Treatment Major Product Offerings
  7.5.4 Pfizer Inc. Non-surgical Lateral Epicondylitis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Non-surgical Lateral Epicondylitis Treatment Market Opportunities & Trends in Global Market
Table 2. Non-surgical Lateral Epicondylitis Treatment Market Drivers in Global Market
Table 3. Non-surgical Lateral Epicondylitis Treatment Market Restraints in Global Market
Table 4. Key Players of Non-surgical Lateral Epicondylitis Treatment in Global Market
Table 5. Top Non-surgical Lateral Epicondylitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Non-surgical Lateral Epicondylitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Non-surgical Lateral Epicondylitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Non-surgical Lateral Epicondylitis Treatment Product Type
Table 9. List of Global Tier 1 Non-surgical Lateral Epicondylitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-surgical Lateral Epicondylitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Non-surgical Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Non-surgical Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Non-surgical Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Non-surgical Lateral Epicondylitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Non-surgical Lateral Epicondylitis Treatment Product Offerings
Table 32. Bayer AG Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline plc. Corporate Summary
Table 34. GlaxoSmithKline plc. Non-surgical Lateral Epicondylitis Treatment Product Offerings
Table 35. GlaxoSmithKline plc. Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services, Inc. Corporate Summary
Table 37. Johnson & Johnson Services, Inc. Non-surgical Lateral Epicondylitis Treatment Product Offerings
Table 38. Johnson & Johnson Services, Inc. Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck Sharp & Dohme Corp. Corporate Summary
Table 40. Merck Sharp & Dohme Corp. Non-surgical Lateral Epicondylitis Treatment Product Offerings
Table 41. Merck Sharp & Dohme Corp. Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Inc. Corporate Summary
Table 43. Pfizer Inc. Non-surgical Lateral Epicondylitis Treatment Product Offerings
Table 44. Pfizer Inc. Non-surgical Lateral Epicondylitis Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Non-surgical Lateral Epicondylitis Treatment Segment by Type in 2021
Figure 2. Non-surgical Lateral Epicondylitis Treatment Segment by Application in 2021
Figure 3. Global Non-surgical Lateral Epicondylitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Non-surgical Lateral Epicondylitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Non-surgical Lateral Epicondylitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-surgical Lateral Epicondylitis Treatment Revenue in 2021
Figure 8. By Type - Global Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Non-surgical Lateral Epicondylitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Non-surgical Lateral Epicondylitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Non-surgical Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline plc. Non-surgical Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services, Inc. Non-surgical Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Sharp & Dohme Corp. Non-surgical Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inc. Non-surgical Lateral Epicondylitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications